Usmarapride
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02575482)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 4 (5-HT4) receptorPARTIAL AGONIST
HTR4 partial agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- suvn-d4010
- suvn-d4010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03031574 | Phase 1 | Jan 23, 2017 | Pharmaceutical Research Associates, Inc. (PRA), Suven Life Sciences Limited |
| NCT02575482 | Phase 1 | Jul 1, 2015 | Suven Life Sciences Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suven Life Sciences Limited | For profit | 2 | 2 | 1 | 2015 |
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1